Harbin Gloria Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 14.58% vs -16.80% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -28.05% vs 21.63% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "539.10",
          "val2": "470.50",
          "chgp": "14.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "75.60",
          "val2": "41.60",
          "chgp": "81.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.70",
          "chgp": "28.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "17.60",
          "val2": "-31.70",
          "chgp": "155.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "96.70",
          "val2": "134.40",
          "chgp": "-28.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.20%",
          "val2": "40.10%",
          "chgp": "10.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -12.58% vs -7.06% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 57.69% vs 88.42% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,116.00",
          "val2": "2,420.40",
          "chgp": "-12.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "317.70",
          "val2": "312.00",
          "chgp": "1.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "10.00",
          "chgp": "-70.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-16.30",
          "chgp": "95.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "382.40",
          "val2": "242.50",
          "chgp": "57.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "107.20%",
          "val2": "91.20%",
          "chgp": "1.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

539.10

470.50

14.58%

Operating Profit (PBDIT) excl Other Income

75.60

41.60

81.73%

Interest

0.90

0.70

28.57%

Exceptional Items

17.60

-31.70

155.52%

Consolidate Net Profit

96.70

134.40

-28.05%

Operating Profit Margin (Excl OI)

140.20%

40.10%

10.01%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 14.58% vs -16.80% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -28.05% vs 21.63% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,116.00

2,420.40

-12.58%

Operating Profit (PBDIT) excl Other Income

317.70

312.00

1.83%

Interest

3.00

10.00

-70.00%

Exceptional Items

-0.80

-16.30

95.09%

Consolidate Net Profit

382.40

242.50

57.69%

Operating Profit Margin (Excl OI)

107.20%

91.20%

1.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -12.58% vs -7.06% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 57.69% vs 88.42% in Dec 2024

All Annual Results